These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 15168799)

  • 21. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
    Sergerie Y; Boivin G
    Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
    Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
    Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
    Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
    Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.
    Coen N; Duraffour S; Topalis D; Snoeck R; Andrei G
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7312-23. PubMed ID: 25267682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative activity of various compounds against clinical strains of herpes simplex virus.
    Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.
    Morfin F; Thouvenot D; De Turenne-Tessier M; Lina B; Aymard M; Ooka T
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2412-6. PubMed ID: 10508017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
    Morfin F; Frobert E; Thouvenot D
    Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
    Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
    Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants.
    Ida M; Kageyama S; Sato H; Kamiyama T; Yamamura J; Kurokawa M; Morohashi M; Shiraki K
    Antiviral Res; 1999 Jan; 40(3):155-66. PubMed ID: 10027650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral activity of ganciclovir elaidic acid ester against herpesviruses.
    Andrei G; Snoeck R; Neyts J; Sandvold ML; Myhren F; De Clercq E
    Antiviral Res; 2000 Mar; 45(3):157-67. PubMed ID: 10771080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.
    Hasegawa T; Kurokawa M; Yukawa TA; Horii M; Shiraki K
    Antiviral Res; 1995 Jun; 27(3):271-9. PubMed ID: 8540749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
    Suzutani T; Ishioka K; De Clercq E; Ishibashi K; Kaneko H; Kira T; Hashimoto K; Ogasawara M; Ohtani K; Wakamiya N; Saijo M
    Antimicrob Agents Chemother; 2003 May; 47(5):1707-13. PubMed ID: 12709344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
    Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
    J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase.
    Hussein IT; Menashy RV; Field HJ
    Antiviral Res; 2008 Jun; 78(3):268-74. PubMed ID: 18325606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel agents for the therapy of varicella-zoster virus infections.
    Snoeck R; Andrei G; De Clercq E
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1743-51. PubMed ID: 11060773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.
    Ng TI; Shi Y; Huffaker HJ; Kati W; Liu Y; Chen CM; Lin Z; Maring C; Kohlbrenner WE; Molla A
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1629-36. PubMed ID: 11353604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.